GlassScriptPhysician profile
William C Napier
NPI 1730443763
$2,207.84
in general payments reported to CMS, 2019-2025
26 companies · $599 in 2025
The $599 reported for 2025 was more than what 76% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.73 · 2022: $528 · 2023: $390 · 2024: $660 · 2025: $599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,649.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $503.74 | 2022-2025 | |
| Novo Nordisk INC | $288.80 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $180.92 | 2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $162.58 | 2024-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $146.14 | 2022-2025 | Evenity, Prolia, Aimovig |
| Pfizer INC. | $112.46 | 2021-2025 | |
| Exact Sciences Corporation | $107.56 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $74.53 | 2021-2024 | Trelegy Ellipta, Arexvy |
| Shield Therapeutics INC | $69.84 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.67 | 2024-2025 | Ofev, Jardiance |
| Amarin Pharma, INC. | $51.24 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.33 | 2023-2025 | Xifaxan |
| Abbott Laboratories | $48.86 | 2023-2024 | Freestyle Libre 3, Freestyle Libre |
| Astellas Pharma US INC | $48.71 | 2023-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $44.19 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $42.16 | 2022 | |
| Phathom Pharmaceuticals, INC. | $32.38 | 2024-2025 | Voquezna |
| Dexcom, INC. | $28.49 | 2023 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $26.59 | 2024 | Gardasil 9, Gardasil, Capvaxive |
| Verity Pharmaceuticals INC. | $25.78 | 2025 | Tlando |
| Takeda Pharmaceuticals U.S.A., INC. | $23.80 | 2024 | Trintellix |
| Axsome Therapeutics, INC. | $20.60 | 2023 | Sunosi |
| Biohaven Pharmaceutical Holding Company LTD. | $18.41 | 2022 | |
| Amneal Pharmaceuticals LLC | $15.43 | 2022 | |
| Eisai INC. | $15.05 | 2025 | |
| Novartis Pharmaceuticals Corporation | $13.58 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Napier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.